Manfred Kaufmann

22.2k citations

150 papers · 14.4k indexed · 6 hit papers · h-index 56

Impact in

Cancer Research top 0.05%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Oncology top 0.1%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis

Papers in

Cancer Research 59
- Breast Cancer Treatment Studies 51
Oncology 72
- HER2/EGFR in Cancer Research 35
- Cancer Treatment and Pharmacology 16
- Cancer-related Molecular Pathways 10
- Cancer Cells and Metastasis 10

Co-authors: Gϋnter von Minckwitz Sibylle Loibl Serban Dan Costa Jens‐Uwe Blohmer J. Hilfrich Holger Eidtmann Christian Jackisch W. Eiermann
Journals: Journal of Clinical Oncology (19 papers)European Journal of Cancer (7 papers)Breast Cancer Research and Treatment (7 papers)Breast Cancer Research (6 papers)International Journal of Cancer (5 papers)
Partner nations: Germany United States United Kingdom

In The Last Decade

Manfred Kaufmann

148 papers receiving 14.0k citations

Hit Papers

6 papers align trajectories log scale

Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes 2012 · 1.8k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 Journal of Clinical Oncology
2009 Journal of Clinical Oncology
2009 Journal of Clinical Oncology
2006 Journal of Clinical Oncology
2005 The Lancet
1998 New England Journal of Medicine

Peers

Countries citing papers authored by Manfred Kaufmann

Since Specialization

Citations

This map shows the geographic impact of Manfred Kaufmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manfred Kaufmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manfred Kaufmann more than expected).

Fields of papers citing papers by Manfred Kaufmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manfred Kaufmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manfred Kaufmann. The network helps show where Manfred Kaufmann may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Manfred Kaufmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Manfred Kaufmann Line = papers co-authored together Manfred Kaufmann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer – results from the HER-OS patient registry BMC Cancer ·Isabell Witzel, Volkmar Müller, Wolfgang Abenhardt, Manfred Kaufmann, Winfried Schoenegg, 杜德兵, F. Jänicke	2014	31
2	Response-Guided Neoadjuvant Chemotherapy for Breast Cancer Journal of Clinical Oncology ·Gϋnter von Minckwitz, Jens‐Uwe Blohmer, Serban Dan Costa, Carsten Denkert, Holger Eidtmann, W. Eiermann, Bernd Gerber, Claus Hanusch, J. Hilfrich, Jens Huober, Christian Jackisch, Manfred Kaufmann, Sherko Kümmel, Stefan Paepke, Andreas Schneeweiß, Michael Untch, Dirk M. Zahm, Keyur Mehta, Sibylle Loibl	2013	265
3	Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial The Lancet Oncology ·Paul E. Goss, Ian E. Smith, Joyce O’Shaughnessy, Bent Ejlertsen, Manfred Kaufmann, Frances Boyle, Aman U. Buzdar, P. Fumoleau, William J. Gradishar, Miguel Martín, Beverly Moy, Martine Piccart, Kathleen I. Pritchard, Deborah Lindquist, Yanin Chávarri-Guerra, Gursel Aktan, Erica Rappold, Lisa S. Williams, Dianne M. Finkelstein	2012	100
4	Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation European Journal of Cancer ·Thomas Karn, Lajos Pusztai, Eugen Ruckhäberle, Cornelia Liedtke, Volkmar Müller, Marcus Schmidt, Dirk Metzler, Jing Wang, Kevin R. Coombes, R. Gätje, Lars Hanker, Christine Solbach, A. Ahr, Uwe Holtrich, Achim Rody, Manfred Kaufmann	2011	39
5	Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ International Journal of Cancer ·Nicole Sänger, Katharina E. Effenberger, Sabine Riethdorf, Mutia Rahmah, J. F. H. Gauwerky, Inka Wiegratz, Klaus Strebhardt, Manfred Kaufmann, Klaus Pantel	2011	111
6	SATB1 gene expression and breast cancer prognosis The Breast ·Lars Hanker, Thomas Karn, James R. MACDONALD, Eugen Ruckhäberle, R. Gaetje, Uwe Holtrich, Manfred Kaufmann, Achim Rody, Inka Wiegratz	2010	38
7	Breast Cancer Proteomics – Differences in Protein Expression between Estrogen Receptor-Positive and -Negative Tumors Identified by Tandem Mass Tag Technology Breast Care ·Eugen Ruckhäberle, Thomas Karn, Lars Hanker, Josef Schwarz, Peter Schulz‐Knappe, Karsten Kuhn, Derya S. Karabulut, Stefan Selzer, М А Бичурина, Knut Engels, Uwe Holtrich, Manfred Kaufmann, Achim Rody	2010	5
8	Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen Journal of Clinical Oncology ·Mitch Dowsett, Jack Cuzick, J. N. Ingle, Alan S. Coates, John Forbes, Judith M. Bliss, Marc Buyse, Michael Baum, Aman U. Buzdar, Marco Colleoni, R. Charles Coombes, Claire Snowdon, Michael Gnant, R. Jakesz, Manfred Kaufmann, Francesco Boccardo, Jon Godwin, Christina Davies, Richárd Pető Hit paper breakdown →	2009	581
9	Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy Breast Cancer Research ·Silvia Darb‐Esfahani, Sibylle Loibl, Berit Müller, Marc Roller, Carsten Denkert, Martina Komor, Karsten Schlüns, Jens‐Uwe Blohmer, Jan Budczies, Bernd Gerber, Aurelia Noske, Andreas du Bois, Wilko Weichert, Christian Jackisch, Manfred Dietel, Klaus Richter, Manfred Kaufmann, Gϋnter von Minckwitz	2009	91
10	T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers Breast Cancer Research ·Achim Rody, Uwe Holtrich, L. Pusztai, Cornelia Liedtke, R. Gaetje, Eugen Ruckhaeberle, Christine Solbach, Lars Hanker, A. Ahr, Dirk Metzler, Knut Engels, Thomas Karn, Manfred Kaufmann	2009	336
11	Gene expression of ceramide kinase, galactosyl ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancer Journal of Cancer Research and Clinical Oncology ·Eugen Ruckhäberle, Thomas Karn, Achim Rody, Lars Hanker, R. Gätje, Dirk Metzler, Uwe Holtrich, Manfred Kaufmann	2009	84
12	Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancer Journal of Cancer Research and Clinical Oncology ·Eugen Ruckhäberle, Thomas Karn, Lars Hanker, R. Gätje, Dirk Metzler, Uwe Holtrich, Manfred Kaufmann, Achim Rody	2008	33
13	Poor Outcome in Estrogen Receptor–Positive Breast Cancers Predicted by Loss of Plexin B1 Clinical Cancer Research ·Achim Rody, Uwe Holtrich, R. Gaetje, Mathias Gehrmann, Knut Engels, Gϋnter von Minckwitz, Sibylle Loibl, Chao Jiang, Eugen Ruckhäberle, Dirk Metzler, A. Ahr, Christine Solbach, Thomas Karn, Manfred Kaufmann	2007	54
14	Long-term risk of breast cancer recurrence: the need for extended adjuvant therapy Journal of Cancer Research and Clinical Oncology ·Manfred Kaufmann, Achim Rody	2005	25
15	Osteoporosis case finding in the general practice: phalangeal radiographic absorptiometry with and without risk factors for osteoporosis to select postmenopausal women eligible for lumbar spine and hip densitometry Osteoporosis International ·Shitole Kishor Maruti, Christian Mueller, Marcel Zwahlen, Manfred Kaufmann, Khon Le, Romain Perrelet, Román García de Alba, Ulrich Bürgi, Kurt Lippuner	2005	8
16	From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression Proceedings of the National Academy of Sciences ·Oleg Schmidt‐Kittler, Thomas Ragg, G. Sarquella-Brugada, Martin Granzow, A. Ahr, Thomas Blankenstein, Manfred Kaufmann, Joachim Diebold, H Arnholdt, Peter E. Müller, Joachim Bischoff, Yadi Hariyadi, Günter Schlimok, Gert Riethmüller, Roland Eils, Christoph A. Klein	2003	493
17	Cooperative phosphorylation including the activity of polo-like kinase 1 regulates the subcellular localization of cyclin B1 Oncogene ·Juping Yuan, Frank Eckerdt, Jürgen Bereiter‐Hahn, Elisabeth Kurunci‐Csacsko, Manfred Kaufmann, Klaus Strebhardt	2002	102
18	Predictive value of serum interleukin‐6 and ‐8 levels in preterm labor or rupture of the membranes Acta Obstetricia Et Gynecologica Scandinavica ·Gϋnter von Minckwitz, E.‐M. Grischke, M. Shinohara, Xuansong Wang, Sibylle Loibl, M. Aulmann, Manfred Kaufmann	2000	60
19	Microvessel density, expression of proto-oncogenes, resistance-related proteins and incidence of metastases in primary ovarian carcinomas Clinical & Experimental Metastasis ·M Volm, Reet Koomägi, Manfred Kaufmann, Jürgen Mattern, G. Stammler	1996	12
20	Human breast tumors containing non-DNA-binding immunoreactive (67 kDa) estrogen receptor Breast Cancer Research and Treatment ·Shiobhán Hellberg Falguera, Gary K. Scott, Michael C. Luce, Manfred Kaufmann, Christopher C. Benz	1993	11

About Manfred Kaufmann

Manfred Kaufmann is a scholar working on Cancer Research, Oncology, Reproductive Medicine, Pathology and Forensic Medicine and Obstetrics and Gynecology, having authored 150 papers that have together received 14.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (51 papers), HER2/EGFR in Cancer Research (35 papers), Estrogen and related hormone effects (20 papers), Breast Lesions and Carcinomas (16 papers), Cancer Treatment and Pharmacology (16 papers), Endometriosis Research and Treatment (11 papers), Cancer-related Molecular Pathways (10 papers) and Cancer Cells and Metastasis (10 papers). The work is most often cited by research in Cancer Research (6.8k citations), Oncology (8.3k citations), Pathology and Forensic Medicine (2.3k citations), Radiology, Nuclear Medicine and Imaging (1.9k citations) and Genetics (2.2k citations). Manfred Kaufmann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Gϋnter von Minckwitz, Sibylle Loibl, Serban Dan Costa, Jens‐Uwe Blohmer, J. Hilfrich, Holger Eidtmann, Christian Jackisch, W. Eiermann, Michael Untch and Bernd Gerber. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Breast Cancer Research and Treatment, Breast Cancer Research and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact